The FDA is approved a first-of-its-kind implantable electrical nerve stimulator device to treat severe depression.

The Vagus Nerve Stimulation (VNS) System is approved for adult patients with long-term or recurrent major depression that has not responded properly to four or more antidepressant treatments

The FDA is approved a first-of-its-kind implantable electrical nerve stimulator device to treat severe depression.

The Vagus Nerve Stimulation (VNS) System is approved for adult patients with long-term or recurrent major depression that has not responded properly to four or more antidepressant treatments

The FDA is approved a first-of-its-kind implantable electrical nerve stimulator device to treat severe depression.

The Vagus Nerve Stimulation (VNS) System is approved for adult patients with long-term or recurrent major depression that has not responded properly to four or more antidepressant treatments

The FDA cleared a device, known as the Vagus Nerve Stimulation Therapy System (VNS), for long-term use for patients with depression.

The device is implanted in the chest and sends impulses to the brain through a nerve in the neck

A study from the University of Michigan claims rich people die differently from the rest of the population.

The study, appearing in the August issue of the Journal for Palliative Care, says wealthier people are less likely than poor ones to suffer pain at the end of their lives, and wealthier elders experienced a lower number of symptoms overall